The Treatment Period for Pediatric COVID-19 Patients is Reviewed from the Use of Antibiotics
- Author Irma Yanti Rangkuti
- Co-Author Siti Kemala Sari, Lucia Aktalina, Mayang Sari Ayu
- DOI https://ww
- Country : Indonesia
- Subject : Pharmacology
Keywords : Antibiotics, Azithromycin, Ceftriaxone, COVID-19, The Treatment Period.
Abstract
Antibiotics were used in Covid-19 infection. The study's objective was to examine the children patients' length of stay in Covid 19, those who received antibiotics and those who did not. Fifty-seven children ranging from 1 to 17 years old, consisted of twenty-eight females and 29 males. Fifty-one individuals took antibiotics, whereas six did not. Out of the 51 individuals, 12 received azithromycin, and 39 received ceftriaxone. Patients who get ceftriaxone undergo treatment for seven days, with a minimum of 3 days and a maximum of 29 days. Azithromycin treatment for patients lasts 6.5 days, with a minimum of 3 days and a maximum of 11 days. Patients who were not receiving antibiotics must undergo treatment for a minimum of 2 days and a maximum of 15 days. For pediatric Covid patients, there was no difference in length of stay between those receiving azithromycin, ceftriaxone, or no antibiotics (P=0.684).
Comments
No have any comment !